We are live on ! Find out more
CC

Callan Capital Portfolio holdings

AUM $1.35B
1-Year Est. Return 8.35%
This Fund
S&P 500
This Quarter Est. Return
-0.8%
1 Year Est. Return
+8.35%
3 Year Est. Return
+20.11%
5 Year Est. Return
+98.58%
10 Year Est. Return
+95.87%
AUM
$245M
AUM Growth
+$6.42M
Cap. Flow
+$10.6M
Cap. Flow %
4.35%
Top 10 Hldgs %
74.43%
Holding
71
New
8
Increased
23
Reduced
20
Closed
3

Top Buys

Rank Stock Value
1
VCSH icon
Vanguard Short-Term Corporate Bond ETF
VCSH
+$3.19M
2
VEU icon
Vanguard FTSE All-World ex-US ETF
VEU
+$2.07M
3
BND icon
Vanguard Total Bond Market
BND
+$2.06M
4
GSLC icon
Goldman Sachs ActiveBeta US Large Cap Equity ETF
GSLC
+$1.63M
5
FNDB icon
Schwab Fundamental US Broad Market Index ETF
FNDB
+$1.33M

Top Sells

Rank Stock Value
1
SCHB icon
Schwab US Broad Market ETF
SCHB
+$1.46M
2
SCHF icon
Schwab International Equity ETF
SCHF
+$742K
3
NBIX icon
Neurocrine Biosciences
NBIX
+$322K
4
DBEF icon
Xtrackers MSCI EAFE Hedged Equity ETF
DBEF
+$279K
5
RMD icon
ResMed
RMD
+$263K

Sector Composition

Rank Sector Weight
1 Miscellaneous 86.18%
2 Healthcare 12.42%
3 Real Estate 0.47%
4 Financials 0.35%
5 Materials 0.26%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ARE icon
26
Alexandria Real Estate Equities
ARE
$8.87B
$1.15M 0.47%
11,108
-421
-4% -$40.2K
SCHF icon
27
Schwab International Equity ETF
SCHF
$69.3B
$1.13M 0.46%
83,662
-54,238
-39% -$742K
AMLP icon
28
Alerian MLP ETF
AMLP
$13.4B
$1.1M 0.45%
17,297
+340
+2% +$20.5K
RMD icon
29
ResMed
RMD
$34.7B
$1.02M 0.42%
16,183
-4,458
-22% -$263K
BIIB icon
30
Biogen
BIIB
$32.3B
$881K 0.36%
3,644
-552
-13% -$145K
EWJ icon
31
iShares MSCI Japan ETF
EWJ
$22.7B
$806K 0.33%
17,511
+2,723
+18% +$127K
FNDF icon
32
Schwab Fundamental International Large Company Index ETF
FNDF
$26B
$781K 0.32%
+32,890
New +$787K
NBIX icon
33
Neurocrine Biosciences
NBIX
$15.7B
$682K 0.28%
15,000
-7,000
-32% -$322K
SCHE icon
34
Schwab Emerging Markets Equity ETF
SCHE
$13B
$640K 0.26%
30,062
-180
-0.6% -$3.7K
MON
35
DELISTED
Monsanto Co
MON
$631K 0.26%
6,098
– –
VDE icon
36
Vanguard Energy ETF
VDE
$10.7B
$600K 0.25%
6,308
-1,170
-16% -$108K
MBFI
37
DELISTED
MB Financial Corp
MBFI
$504K 0.21%
13,905
-1,800
-11% -$62.1K
RLY icon
38
State Street Multi-Asset Real Return ETF
RLY
$1.35B
$490K 0.2%
20,130
– –
DSI icon
39
iShares MSCI KLD 400 Social ETF
DSI
$5.53B
$461K 0.19%
11,908
-650
-5% -$25K
MLPX icon
40
Global X MLP & Energy Infrastructure ETF
MLPX
$3.63B
$449K 0.18%
10,834
– –
AAXJ icon
41
iShares MSCI All Country Asia ex Japan ETF
AAXJ
$3.88B
$447K 0.18%
8,172
-758
-8% -$40.5K
KND
42
DELISTED
Kindred Healthcare
KND
$446K 0.18%
39,494
+6,416
+19% +$80.3K
CMBS icon
43
iShares CMBS ETF
CMBS
$472M
$421K 0.17%
7,910
– –
AGIO icon
44
Agios Pharmaceuticals
AGIO
$1.99B
$419K 0.17%
10,000
+3,000
+43% +$148K
EBND icon
45
State Street SPDR Bloomberg Emerging Markets Local Bond ETF
EBND
$2.29B
$376K 0.15%
13,503
– –
DXJ icon
46
WisdomTree Japan Hedged Equity Fund
DXJ
$7.34B
$372K 0.15%
9,592
-989
-9% -$41.7K
EWC icon
47
iShares MSCI Canada ETF
EWC
$6.85B
$368K 0.15%
15,022
+3,222
+27% +$78.9K
ZVO
48
DELISTED
Zovio Inc. Common Stock
ZVO
$355K 0.14%
49,036
+4,975
+11% +$42.6K
MINT icon
49
PIMCO Enhanced Short Maturity Active Exchange-Traded Fund
MINT
$17.4B
$314K 0.13%
+3,103
New +$313K
CELG
50
DELISTED
Celgene Corp
CELG
$306K 0.12%
3,100
– –
1
2
3

Similar funds

MBA
Maple-Brown Abbott Barangaroo, Australia $1.47B AUM 27.26% 1-Year Est. Return
SIA
Schechter Investment Advisors Birmingham, Michigan $1.21B AUM 8.73% 1-Year Est. Return
AP
Adero Partners Pleasanton, California $1.53B AUM 5.52% 1-Year Est. Return
MW
Marcum Wealth Cleveland, Ohio $1.16B AUM 6.7% 1-Year Est. Return
SBIA
Sheaff Brock Investment Advisors Indianapolis, Indiana $1.09B AUM 14.4% 1-Year Est. Return
LC
Lindbrook Capital Calabasas, California $1.08B AUM 10.14% 1-Year Est. Return
TW
Transform Wealth Greenwood Village, Colorado $1.65B AUM 19.1% 1-Year Est. Return
PAME
Parvus Asset Management Europe London, United Kingdom $1.67B AUM

Callan Capital's Q2 2016 Portfolio in Review

As of Q2 2016, Callan Capital held 71 positions worth $245M, up 2.7% from $239M the previous quarter. Its ten largest holdings account for 74% of the portfolio.

Callan Capital deployed $10.6M of net new capital in Q2 2016, opening 8 new positions and adding to 23 existing holdings. Its largest new stake was Schwab Fundamental US Broad Market Index ETF: 134,202 shares worth $1.34M.

By sector, the portfolio is most concentrated in Miscellaneous at 86% of assets, up from 83% a quarter earlier, followed by Healthcare and Real Estate.

On the sell side, the largest reduction was Schwab US Broad Market ETF, an estimated $1.46M trimmed.

  • Callan Capital's largest Q2 2016 buy was Schwab Fundamental US Broad Market Index ETF: 134,202 shares worth $1.34M.
  • Callan Capital added most to Vanguard Short-Term Corporate Bond ETF in Q2 2016, an estimated $3.19M increase.
  • Callan Capital's biggest Q2 2016 reduction was Schwab US Broad Market ETF, cutting an estimated $1.46M.
  • Callan Capital fully exited Xtrackers MSCI EAFE Hedged Equity ETF in Q2 2016, selling an estimated $279K.
  • Callan Capital's ten largest holdings make up 74% of its $245M portfolio in Q2 2016.
  • Callan Capital opened 8 new positions and closed 3 in Q2 2016.
  • Callan Capital's portfolio value rose 2.7% quarter-over-quarter to $245M.

Based on Callan Capital's 13F filing for Q2 2016, filed 12 Aug 2016.